ESOPHAGEAL SQUAMOUS CELL CANCER (SCC)

Clinical trials for ESOPHAGEAL SQUAMOUS CELL CANCER (SCC) explained in plain language.

Never miss a new study

Get alerted when new ESOPHAGEAL SQUAMOUS CELL CANCER (SCC) trials appear

Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CANCER (SCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New weapon against advanced cancer enters human testing

Disease control Recruiting now

This is the first study in people testing a new cancer drug called MGC026. It aims to find a safe dose and see if the drug can help shrink tumors in adults with advanced solid tumors that have not responded to other treatments. The study will also check how the drug moves through…

Matched conditions: ESOPHAGEAL SQUAMOUS CELL CANCER (SCC)

Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

ESOPHAGEAL SQUAMOUS CELL CANCER (SCC)

Get alerted when new ESOPHAGEAL SQUAMOUS CELL CANCER (SCC) trials appear

New weapon against advanced cancer enters human testing